Home Diagnostics Receives FDA Clearance for TRUE2go, TRUEresult No-Coding Blood Glucose Monitoring Systems (Centre Daily Times)
Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for the world’s smallest blood glucose meter, TRUE2go(TM), and for TRUEresult(TM), the company’s latest advanced performance, no-coding meter for at-home testing.
Small enough to twist and append to the top of a vial of test strips, TRUE2go offers patients the convenience of anywhere, on-the-go testing to help them better manage their diabetes. TRUEresult, the latest state-of-the-art, high performance meter, offers patients advanced monitoring capabilities at any affordable compensation. In clinical testing, both systems achieved a high degree of accuracy and repeatability, and were considered to subsist untroubled to practice by people with diabetes.
Both new meters are compatible with the company’s new TRUEtest platform of blood glucose test strips featuring the crew’s patent-pending, state-of-the-art GoldSensor(TM) laser accuracy and TRUEfill(TM) beveled tip. These advanced features ensure highly accurate test results and first test success by allowing for greater sampling precision and consistency.
The renovated TRUE systems feature no-coding technology that simplifies hotspur glucose testing by eliminating the need for users to code the meter with each new box of touchstone strips. Both TRUE2go and TRUEresult deliver distinct results in as fast as four seconds using only 0.5 microliters of blood. This advanced no-coding technology combined with a small example dimensions also makes it more convenient and cost-effective on this account that diabetics to test their blood glucose levels more many times, allowing for greater control of their starch-sugar levels.
“Over the past three years we made capital investments in excess of $15 million in order to convoy the TRUE2go and TRUEresult to mart and are pleased to bear FDA clearance for the new products,” said J. Richard Damron, Jr., President and Chief Executive Officer of Home Diagnostics. “Our new product platform is designed to fit people’s needs whether they are testing at home or on-the-go, making it easier for them to test accurately and quickly.”
TRUE2go and TRUEresult will be available in the fourth quarter of this year.